Otis (OTIS) slides 7.3% as investors weigh post-earnings outlook, downgrades, and technical pressure

Otis Worldwide Corporation (OTIS) is down 7.3% today. Here is some analysis on what might have caused this price movement.

Analysis: The selloff appears to be an extension of negative sentiment following Otis’ latest results and 2026 outlook, alongside a more cautious analyst stance and added technical pressure after the stock broke key support levels. With no single, company-announced headline clearly tied to today’s drop, the move may reflect a cluster of incremental negatives rather than one new catalyst.

Details:

Otis’ most recent quarterly update outlined 2026 expectations that included low- to mid-single-digit organic sales growth and mid- to high-single-digit adjusted EPS growth, with new equipment expected to be down low single digits to flat, keeping attention on demand softness.

At least one major brokerage turned more cautious on the name following the quarter, citing a damaged investment thesis and reducing its price target, which can pressure near-term flows.

The stock recently traded below its 200-day moving average, a level many systematic and technical investors monitor, which can amplify selling when momentum turns negative.

Otis previously completed a $500 million note issuance and disclosed plans to use proceeds to repay notes maturing in March 2026; while balance-sheet management is routine, investors sometimes react to refinancing activity in a risk-off tape.

Sources:

Otis Investor Relations, TipRanks, Nasdaq, Investing.com

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$OTIS Insider Trading Activity

$OTIS insiders have traded $OTIS stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $OTIS stock by insiders over the last 6 months:

JUDITH FRAN MARKS (Chair, CEO and President) has made 0 purchases and 2 sales selling 102,887 shares for an estimated $9,289,408.
MONTLIVAULT STEPHANE DE (President, Otis Asia Pacific) sold 47,944 shares for an estimated $4,423,059
NORA E. LAFRENIERE (EVP, General Counsel) has made 0 purchases and 2 sales selling 27,418 shares for an estimated $2,477,926.
NEIL GREEN (EVP & Chief Digital Officer) sold 6,000 shares for an estimated $518,709
MICHAEL PATRICK RYAN (SVP, CAO & Controller) has made 0 purchases and 2 sales selling 4,210 shares for an estimated $384,092.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$OTIS Hedge Fund Activity

We have seen 500 institutional investors add shares of $OTIS stock to their portfolio, and 673 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

J. STERN & CO. LLP added 38,178,808 shares (+8654.2%) to their portfolio in Q4 2025, for an estimated $3,334,918,878
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 10,041,495 shares (-77.0%) from their portfolio in Q4 2025, for an estimated $877,124,588
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 2,882,950 shares (-92.7%) from their portfolio in Q4 2025, for an estimated $251,825,682
FUNDSMITH LLP removed 2,706,771 shares (-46.5%) from their portfolio in Q4 2025, for an estimated $236,436,446
MILLENNIUM MANAGEMENT LLC added 2,179,314 shares (+1047.0%) to their portfolio in Q4 2025, for an estimated $190,363,077
VAN ECK ASSOCIATES CORP added 1,979,819 shares (+97.9%) to their portfolio in Q4 2025, for an estimated $172,937,189
ALLIANCEBERNSTEIN L.P. removed 1,751,879 shares (-10.3%) from their portfolio in Q4 2025, for an estimated $153,026,630

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$OTIS Congressional Stock Trading

Members of Congress have traded $OTIS stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $OTIS stock by members of Congress over the last 6 months:

REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$OTIS Analyst Ratings

Wall Street analysts have issued reports on $OTIS in the last several months. We have seen 2 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

Barclays issued a "Underweight" rating on 10/30/2025
JP Morgan issued a "Overweight" rating on 10/15/2025
Wolfe Research issued a "Outperform" rating on 10/08/2025

To track analyst ratings and price targets for $OTIS, check out Quiver Quantitative's $OTIS forecast page.

$OTIS Price Targets

Multiple analysts have issued price targets for $OTIS recently. We have seen 4 analysts offer price targets for $OTIS in the last 6 months, with a median target of $100.5.

Here are some recent targets:

Stephen Tusa from JP Morgan set a target price of $116.0 on 01/16/2026
Joseph O'Dea from Wells Fargo set a target price of $92.0 on 12/15/2025
Julian Mitchell from Barclays set a target price of $92.0 on 10/30/2025
Nigel Coe from Wolfe Research set a target price of $109.0 on 10/08/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.